Clinical Review Criteria Radioembolization & Chemoembolization Procedures
Customize your policy alerts
Sign up for all Kaiser Permanente policy alerts
Know when Kaiser Permanente releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs medical-necessity review and coverage of yttrium-90 microsphere radioembolization, including TheraSphere and SIR-Spheres, and transcatheter arterial chemoembolization for Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc. members and providers.
Transcatheter arterial chemoembolization medical-necessity determinations now use MCG guideline A-1075.
The Medical Policy Committee approved adoption of new MCG medical-necessity criteria for transcatheter arterial chemoembolization (TACE).
The applicable code list was updated on February 16, 2022.
The coverage-article link was updated on November 13, 2023 because article A52950 was retired.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.